RECOMBINANT ANTIBODY

Molécule d'anticorps modifié (AAM), dotée d'une région charnière comportant un nombre de résidus de cystéine différent de celui trouvé dans la région charnière normalement associée au domaine CH1 de la molécule d'anticorps, et procédé en permettant la production par une technologie re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BODMER, MARK, WILLIAM, WHITTLE, NIGEL, RICHARD, ADAIR, JOHN, ROBERT
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BODMER, MARK, WILLIAM
WHITTLE, NIGEL, RICHARD
ADAIR, JOHN, ROBERT
description Molécule d'anticorps modifié (AAM), dotée d'une région charnière comportant un nombre de résidus de cystéine différent de celui trouvé dans la région charnière normalement associée au domaine CH1 de la molécule d'anticorps, et procédé en permettant la production par une technologie recombinante à base d'ADN. PCT No. PCT/GB88/00729 Sec. 371 Date Jul. 3, 1989 Sec. 102(e) Date Jul. 3, 1989 PCT Filed Sep. 5, 1988 PCT Pub. No. WO89/01782 PCT Pub. Date Mar. 9, 1989.The present invention provides an altered antibody molecule wherein a residue in a surface pocket on the molecule has been changed to a cysteine residue to introduce a thiol group in the surface pocket and a process for its production by recombinant DNA technology.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP0347433A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP0347433A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP0347433A13</originalsourceid><addsrcrecordid>eNrjZBAJcnX293Xy9HP0C1EAYk8nf5dIHgbWtMSc4lReKM3NoODmGuLsoZtakB-fWlyQmJyal1oS7xpgYGxibmJs7GhoTIQSAESpHj8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>RECOMBINANT ANTIBODY</title><source>esp@cenet</source><creator>BODMER, MARK, WILLIAM ; WHITTLE, NIGEL, RICHARD ; ADAIR, JOHN, ROBERT</creator><creatorcontrib>BODMER, MARK, WILLIAM ; WHITTLE, NIGEL, RICHARD ; ADAIR, JOHN, ROBERT</creatorcontrib><description>Molécule d'anticorps modifié (AAM), dotée d'une région charnière comportant un nombre de résidus de cystéine différent de celui trouvé dans la région charnière normalement associée au domaine CH1 de la molécule d'anticorps, et procédé en permettant la production par une technologie recombinante à base d'ADN. PCT No. PCT/GB88/00729 Sec. 371 Date Jul. 3, 1989 Sec. 102(e) Date Jul. 3, 1989 PCT Filed Sep. 5, 1988 PCT Pub. No. WO89/01782 PCT Pub. Date Mar. 9, 1989.The present invention provides an altered antibody molecule wherein a residue in a surface pocket on the molecule has been changed to a cysteine residue to introduce a thiol group in the surface pocket and a process for its production by recombinant DNA technology.</description><language>eng ; fre ; ger</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES USING MICROORGANISMS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>1989</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19891227&amp;DB=EPODOC&amp;CC=EP&amp;NR=0347433A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19891227&amp;DB=EPODOC&amp;CC=EP&amp;NR=0347433A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BODMER, MARK, WILLIAM</creatorcontrib><creatorcontrib>WHITTLE, NIGEL, RICHARD</creatorcontrib><creatorcontrib>ADAIR, JOHN, ROBERT</creatorcontrib><title>RECOMBINANT ANTIBODY</title><description>Molécule d'anticorps modifié (AAM), dotée d'une région charnière comportant un nombre de résidus de cystéine différent de celui trouvé dans la région charnière normalement associée au domaine CH1 de la molécule d'anticorps, et procédé en permettant la production par une technologie recombinante à base d'ADN. PCT No. PCT/GB88/00729 Sec. 371 Date Jul. 3, 1989 Sec. 102(e) Date Jul. 3, 1989 PCT Filed Sep. 5, 1988 PCT Pub. No. WO89/01782 PCT Pub. Date Mar. 9, 1989.The present invention provides an altered antibody molecule wherein a residue in a surface pocket on the molecule has been changed to a cysteine residue to introduce a thiol group in the surface pocket and a process for its production by recombinant DNA technology.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1989</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBAJcnX293Xy9HP0C1EAYk8nf5dIHgbWtMSc4lReKM3NoODmGuLsoZtakB-fWlyQmJyal1oS7xpgYGxibmJs7GhoTIQSAESpHj8</recordid><startdate>19891227</startdate><enddate>19891227</enddate><creator>BODMER, MARK, WILLIAM</creator><creator>WHITTLE, NIGEL, RICHARD</creator><creator>ADAIR, JOHN, ROBERT</creator><scope>EVB</scope></search><sort><creationdate>19891227</creationdate><title>RECOMBINANT ANTIBODY</title><author>BODMER, MARK, WILLIAM ; WHITTLE, NIGEL, RICHARD ; ADAIR, JOHN, ROBERT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP0347433A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>1989</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>BODMER, MARK, WILLIAM</creatorcontrib><creatorcontrib>WHITTLE, NIGEL, RICHARD</creatorcontrib><creatorcontrib>ADAIR, JOHN, ROBERT</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BODMER, MARK, WILLIAM</au><au>WHITTLE, NIGEL, RICHARD</au><au>ADAIR, JOHN, ROBERT</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>RECOMBINANT ANTIBODY</title><date>1989-12-27</date><risdate>1989</risdate><abstract>Molécule d'anticorps modifié (AAM), dotée d'une région charnière comportant un nombre de résidus de cystéine différent de celui trouvé dans la région charnière normalement associée au domaine CH1 de la molécule d'anticorps, et procédé en permettant la production par une technologie recombinante à base d'ADN. PCT No. PCT/GB88/00729 Sec. 371 Date Jul. 3, 1989 Sec. 102(e) Date Jul. 3, 1989 PCT Filed Sep. 5, 1988 PCT Pub. No. WO89/01782 PCT Pub. Date Mar. 9, 1989.The present invention provides an altered antibody molecule wherein a residue in a surface pocket on the molecule has been changed to a cysteine residue to introduce a thiol group in the surface pocket and a process for its production by recombinant DNA technology.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP0347433A1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
TESTING
VINEGAR
WINE
title RECOMBINANT ANTIBODY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T15%3A38%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BODMER,%20MARK,%20WILLIAM&rft.date=1989-12-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP0347433A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true